NA1-115-7 is the latest type of selective Mcl-1 inhibitor that specifically induces apoptosis in Mcl-1-dependent tumor cells, and two hours of treatment is sufficient to trigger cell death [9]. This evidence concerns the gene MCL1 and neoplasm.